Alcohol
Volume 44, Issue 5 , Pages 401-406, August 2010

Relationship between the serotonin transporter polymorphism and obsessive–compulsive alcohol craving in alcohol-dependent adults: a pilot study

  • Rachel D. Thompson

      Affiliations

    • Tri-State Tobacco and Alcohol Research Center, Addiction Sciences Division, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
  • ,
  • Jaimee L. Heffner

      Affiliations

    • Tri-State Tobacco and Alcohol Research Center, Addiction Sciences Division, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    • Corresponding Author InformationCorresponding author. Tri-State Tobacco and Alcohol Research Center, University of Cincinnati Genome Research Institute, 2120 E. Galbraith Road, Building A, Cincinnati, OH 45237, USA. Tel.: +1-513-558-7187; fax: +1-513-558-7180.
  • ,
  • Judith A. Strong

      Affiliations

    • Pain Research Center, Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA
  • ,
  • Thomas J. Blom

      Affiliations

    • Tri-State Tobacco and Alcohol Research Center, Addiction Sciences Division, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
  • ,
  • Robert M. Anthenelli

      Affiliations

    • Tri-State Tobacco and Alcohol Research Center, Addiction Sciences Division, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    • Cincinnati Veterans Affairs Medical Center, Cincinnati, OH, USA

Received 12 December 2009; received in revised form 27 April 2010; accepted 5 May 2010. published online 05 July 2010.

Abstract 

A serotonin deficiency state has been implicated in alcohol-dependent individuals' experience of obsessive–compulsive alcohol craving. Because the serotonin transporter (5-HTT) functions to remove serotonin from the synapse, it is thought that increased reuptake (indicated by the number of high-expressing LA alleles present in the 5-HTT gene-linked polymorphic region [5-HTTLPR] of the SLC6A4 gene) is associated with an increase in obsessive–compulsive alcohol craving. The current pilot investigation sought to explore this hypothesis by examining the extent to which obsessive–compulsive alcohol craving varies by 5-HTTLPR genotype among participants enrolled in an ongoing pharmacogenetics trial. All participants were screened with a semi-structured diagnostic interview, completed self-report measures of alcohol-related behavior, and underwent peripheral venous blood draw for DNA genotyping. Cross-sectional data obtained at baseline from 176 currently drinking alcohol-dependent individuals were analyzed using multiple regression. Preliminary findings suggest that 5-HTTLPR is not predictive of Obsessive Compulsive Drinking Scale total and factor scores. Although the 5-HTTLPR polymorphism was not related to obsessive–compulsive alcohol craving in this pilot study, additional research is needed to clarify the possible role of serotonergic mechanisms in alcohol craving.

Keywords: 5-HTTLPR, Serotonin transporter, Craving, Obsession, Compulsion, Alcohol dependence

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosures: Drs Heffner, Strong, Ms Thompson, and Mr Blom have no financial disclosures to make. Dr Anthenelli provides consultant, advisory, and/or speakers' bureau services to Sanofi-Aventis and Pfizer. The Tri-State Tobacco and Alcohol Research Center receives research support from Lilly, Nabi Biopharmaceuticals, and Pfizer.

PII: S0741-8329(10)00048-0

doi:10.1016/j.alcohol.2010.05.008

Alcohol
Volume 44, Issue 5 , Pages 401-406, August 2010